Finance

Lists
HKMPF:OTCMKTS
Hikma Pharmaceuticals Plc
21,06 US$
0,00%
(0,00) 1D
8 ოქტ, 15:45:21 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HKMPF...
Mkt. cap
3,31 მლრდ.
Avg. vol.
884,00
Volume
2,56 ათ.
52-wk high
24,32 US$
52-wk low
16,34 US$
Beta
0,93
Shares outstanding
208,75 მლნ.
No. of employees
10 ათ.
Mkt. cap
3,31 მლრდ.
Avg. vol.
884,00
Volume
2,56 ათ.
52-wk high
24,32 US$
52-wk low
16,34 US$
Beta
0,93
Shares outstanding
208,75 მლნ.
No. of employees
10 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
11 საათის წინ
Hikma appoints Rebecca Hall as CFO: what it means for Hikma stock
About Hikma Pharmaceuticals Plc
CEO-
Employees9,5 ათ.
Founded1978
Headquartersლონდონი, ინგლისი, გაერთიანებული სამეფო
SectorPharmaceutical industry
Websitehikma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
845,50 მლნ.
845,50 მლნ.
864,00 მლნ.
864,00 მლნ.
Cost of goods sold
479,50 მლნ.
479,50 მლნ.
477,00 მლნ.
477,00 მლნ.
Cost of revenue
479,50 მლნ.
479,50 მლნ.
477,00 მლნ.
477,00 მლნ.
Research and development expenses
39,00 მლნ.
39,00 მლნ.
43,00 მლნ.
43,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
194,00 მლნ.
194,00 მლნ.
141,00 მლნ.
141,00 მლნ.
Operating expense
229,00 მლნ.
229,00 მლნ.
184,00 მლნ.
184,00 მლნ.
Total operating expenses
708,50 მლნ.
708,50 მლნ.
661,00 მლნ.
661,00 მლნ.
Operating income
137,00 მლნ.
137,00 მლნ.
203,00 მლნ.
203,00 მლნ.
Other non operating income
-6,00 მლნ.
-6,00 მლნ.
-
-
EBT including unusual items
112,00 მლნ.
112,00 მლნ.
143,50 მლნ.
143,50 მლნ.
EBT excluding unusual items
104,00 მლნ.
104,00 მლნ.
178,50 მლნ.
178,50 მლნ.
Income tax expense
28,50 მლნ.
28,50 მლნ.
31,00 მლნ.
31,00 მლნ.
Effective tax rate
25,45%
25,45%
21,60%
21,60%
Other operating expenses
-4,00 მლნ.
-4,00 მლნ.
-
-
Net income
82,00 მლნ.
82,00 მლნ.
111,50 მლნ.
111,50 მლნ.
Net profit margin
9,70%
9,70%
12,90%
12,90%
Earnings per share
-
-
-
-
Interest and investment income
1,00 მლნ.
1,00 მლნ.
1,50 მლნ.
1,50 მლნ.
Interest expense
-22,50 მლნ.
-22,50 მლნ.
-26,00 მლნ.
-26,00 მლნ.
Net interest expenses
-21,50 მლნ.
-21,50 მლნ.
-24,50 მლნ.
-24,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
183,00 მლნ.
183,00 მლნ.
250,50 მლნ.
250,50 მლნ.
Gain or loss from assets sale
500,00 ათ.
500,00 ათ.
-
-
AI content may include mistakes. Learn more
Google აპები